The Radiation Oncology Registry and Biosample Repository

The goal of this study is to establish a registry and biosample repository (defined as blood, urine, and tumor specimens) in patients with a cancer and/or benign tumor diagnosis undergoing radiotherapy.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Neoplasia Neoplasms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Virtua Samson Cancer Center, Moorestown, New Jersey, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Anyone age 18 and above with a cancer and/or benign tumor diagnosis undergoing radiotherapy
Able to sign consent

Treatment and study plan

Primary outcomes

Health Assessments

Time frame: 10 years

Study contacts

Contact information is provided by the study sponsor or research team.

Project Manager

CONTACT

[email protected]

Sponsors and collaborators

Lead sponsor

Abramson Cancer Center at Penn Medicine

Other

Registry information

Official study title

Registry and Biosample Repository

Important dates

Study start: 2008
Primary completion: 2030
Study completion: 2030
First posted: Apr 13, 2012
Registry last updated: Mar 4, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Recruiting